ArticleJournal of medical biochemistry2024
Function evaluation of the autoanalyser internal quality control of the Kehua Polaris c2000 automatic biochemical analyser.
Article in Journal of medical biochemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The present study aims to (1) evaluate the autoanalyser quality control (QC) module of the Kehua Polaris c2000 automatic modularised biochemical analyser and (2) verify the impact of the analyser's automatic implementation of internal QC (IQC) testing at a set time point on the results of IQC and turnaround time (TAT). Methods: For 5 consecutive days, three different methods were used to conduct IQC. Method 1: Internal QC was carried out at 8:00 every day. Method 2: The QC products were placed in the instrument calibration QC plate in the afternoon, and the instrument was set to measure the products at 7:00 the next day automatically. Method 3: The QC products were placed in the instrument calibration QC plate, and the instrument was set up for automatic measurement at 7:30 every day. All three methods were compared and evaluated. The effect of IQC on the TAT was monitored using method 2. Results: There were no statistical differences in the IQC results between methods 2 and 1. However, there were statistical differences in some items between methods 3 and 1; thus, the IQC results of method 2 can be adopted. Implementing method 2 for IQC can help achieve a significant TAT-saving of 35.23 min during the automatic retest process after the IQC indicates an out-of-control situation. This time reduction is highly valuable for improving efficiency and streamlining the testing workflow. Conclusions: Using the autoanalyser QC module of the Kehua Polaris c2000 automatic modular biochemical analysis system to perform IQC has no impact on the IQC test results and can save TAT, as well as automatically correct most out-of-control occurrences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.